Mary Wilson
Well-known member
06 June 2023
doi: https://doi.org/10.1038/d41586-023-01824-1
Sara Reardon
Vaccination against shingles might also prevent dementia, such as that caused by Alzheimer’s disease, according to a study of health records from around 300,000 people in Wales. The analysis found that getting the vaccine lowers the risk of dementia by 20%. But some puzzling aspects of the analysis have stirred debate about the work’s robustness.
The study was published on the medRxiv preprint server on 25 May and has not yet been peer reviewed.
“If it is true, it’s huge,” says Alberto Ascherio, an epidemiologist at Harvard University in Cambridge, Massachusetts, who was not involved in the study. “Even a modest reduction in risk is a tremendous impact.” Dementia–infection link
The idea that viral infection can play a part in at least some dementia cases dates back to the 1990s, when biophysicist Ruth Itzhaki at the University of Manchester, UK, and her colleagues found herpesviruses in the brains of deceased people with dementia[SUP]2[/SUP]. The theory has been controversial among Alzheimer’s researchers. But recent work has suggested that people infected with viruses that affect the brain have higher rates of neurodegenerative diseases[SUP]3[/SUP]. Research has also suggested that those vaccinated against certain viral diseases are less likely to develop dementia[SUP]4[/SUP]. ...
Data have suggested that the vaccine is more effective in people under 80 years old. As a result, only people under 80 when the programme started — those born on or after 2 September 1933 — were eligible to receive the jab in Wales. Those born before 2 September 1933 were ineligible for life.
https://www.nature.com/articles/d41586-023-01824-1
doi: https://doi.org/10.1038/d41586-023-01824-1
Sara Reardon
Vaccination against shingles might also prevent dementia, such as that caused by Alzheimer’s disease, according to a study of health records from around 300,000 people in Wales. The analysis found that getting the vaccine lowers the risk of dementia by 20%. But some puzzling aspects of the analysis have stirred debate about the work’s robustness.
The study was published on the medRxiv preprint server on 25 May and has not yet been peer reviewed.
“If it is true, it’s huge,” says Alberto Ascherio, an epidemiologist at Harvard University in Cambridge, Massachusetts, who was not involved in the study. “Even a modest reduction in risk is a tremendous impact.” Dementia–infection link
The idea that viral infection can play a part in at least some dementia cases dates back to the 1990s, when biophysicist Ruth Itzhaki at the University of Manchester, UK, and her colleagues found herpesviruses in the brains of deceased people with dementia[SUP]2[/SUP]. The theory has been controversial among Alzheimer’s researchers. But recent work has suggested that people infected with viruses that affect the brain have higher rates of neurodegenerative diseases[SUP]3[/SUP]. Research has also suggested that those vaccinated against certain viral diseases are less likely to develop dementia[SUP]4[/SUP]. ...
Data have suggested that the vaccine is more effective in people under 80 years old. As a result, only people under 80 when the programme started — those born on or after 2 September 1933 — were eligible to receive the jab in Wales. Those born before 2 September 1933 were ineligible for life.
https://www.nature.com/articles/d41586-023-01824-1